Cardiovascular Atherosclerosis: Prediction, Prevention and Management 2024

Despite notable advances in management, atherosclerotic cardiovascular disease (ASCVD) and its major clinical manifestations remains a leading cause of both morbidity and mortality worldwide. In the United States alone, ASCVD is the leading cause of death in most racial and ethnic populations and is estimated to cost more than $200 billion per year due to medications, healthcare service utilization, and productivity losses. Many of these human and economic costs are largely attributable to poor implementation of prevention strategies in adults and failure to control ASCVD risk factors using available medications and lifestyle interventions. The Scripps Cardiovascular Atherosclerosis conference is designed to assist clinicians in the prevention, diagnosis, treatment, and ongoing management of ASCVD among patients in their clinical practices as well as to promote increased awareness of prudent lifestyle and dietary choices to improve patient outcomes.

URL:
Tickets: https://go.evvnt.com/2267592-0?pid=176 

Time: 7:00 AM - 5:00 PM

Prices:
Physicians (MD, DO, MBBS): USD 300.00,
RN, NP, PA, Other: USD 225.00,
Students, Residents, Fellows: USD 100.00